These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7185522)

  • 21. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptom management.
    O'Connor P
    Adv Neurol; 2006; 98():227-55. PubMed ID: 16400837
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
    Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
    Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis and spasticity.
    Haselkorn JK; Loomis S
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):467-81. PubMed ID: 15893682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychic syndromes in Basedow's disease and thyroidectomy; therapeutic effectiveness of sleep therapy].
    DAZZI P; ROSSINI R
    Riv Neurol; 1954; 24(2):305. PubMed ID: 13195506
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacotherapy of spinal spasticity: a decade of progress I. Theoretical aspects.
    Segatore M; Miller M
    SCI Nurs; 1994 Aug; 11(3):66-9. PubMed ID: 7792570
    [No Abstract]   [Full Text] [Related]  

  • 32. Mexiletine for treatment of spasticity due to neurological disorders.
    Jimi T; Wakayama Y
    Muscle Nerve; 1993 Aug; 16(8):885. PubMed ID: 8332148
    [No Abstract]   [Full Text] [Related]  

  • 33. Chlorpromazine (thorazine) for mental illness in the presence of pulmonary tuberculosis.
    PLEASURE H
    Psychiatr Q; 1956 Jan; 30(1):23-30. PubMed ID: 13323095
    [No Abstract]   [Full Text] [Related]  

  • 34. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
    Bedlack RS; Pastula DM; Hawes J; Heydt D
    Amyotroph Lateral Scler; 2009 Aug; 10(4):210-5. PubMed ID: 18821142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chlorpromazine in rehabilitation in spastic paralysis].
    KRIZ K
    Cesk Neurol; 1956 Nov; 19(4):242-7. PubMed ID: 13383593
    [No Abstract]   [Full Text] [Related]  

  • 37. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysesthesia perceived as painful spasticity: A report of 3 cases.
    Ordia JI; Fischer E; Adamski E; Spatz EL
    Arch Phys Med Rehabil; 2001 May; 82(5):697-9. PubMed ID: 11346852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of largactil (chlorpromazine) on human spasticity and electromyogram; preliminary report.
    BASMAJIAN JV; SZATMARI A
    AMA Arch Neurol Psychiatry; 1955 Feb; 73(2):224-31. PubMed ID: 13227675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.